Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells

European Journal of Pharmaceutical Sciences - Tập 10 - Trang 195-204 - 2000
Shinji Yamashita1, Tomoyuki Furubayashi2, Makoto Kataoka1, Toshiyasu Sakane1, Hitoshi Sezaki1, Hideaki Tokuda3
1Faculty of Pharmaceutical Sciences, Setsunan University, Nagaotoge-cho 45-1, Hirakata, Osaka 573-0101, Japan
2Toko Pharmaceutical, Honjyo-higashi, Kita-ku, Osaka 531-0074, Japan
3Fujisawa Pharmaceutical, Kashima, Yodogawa-ku, Osaka 532-8514, Japan

Tài liệu tham khảo

Amidon, 1988, Estimating human oral fraction dose absorbed: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds, Pharm. Res., 5, 651, 10.1023/A:1015927004752 Amidon, 1995, A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res., 12, 413, 10.1023/A:1016212804288 Artursson, 1991, Correlation between oral drug absorption in human and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem. Biophys. Res. Commun., 175, 880, 10.1016/0006-291X(91)91647-U Blais, 1987, Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon, J. Membrane Biol., 99, 113, 10.1007/BF01871231 Chen, 1994, Mechanisms and kinetics of uptake and efflux of l-methionine in an intestinal epithelial model (Caco-2), J. Nutr., 124, 1907, 10.1093/jn/124.10.1907 Chong, 1996, In vitro permeability through Caco-2 cells is not quantitatively predictive of in vitro absorption for peptide-like drugs absorbed via the dipeptide transporter system, Pharm. Res., 13, 120, 10.1023/A:1016045820933 Cogburn, 1991, A model of human small intestinal absorptive cells. 1. Transport barrier, Pharm. Res., 8, 210, 10.1023/A:1015844104539 Dantzig, 1990, Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2, Biochim. Biophys. Acta, 1027, 211, 10.1016/0005-2736(90)90309-C Fisher, 1999, Midazolam metabolism by modified Caco-2 monolayers: Effects of extracellular protein binding, J. Pharmacol. Exp. Ther., 289, 1143 Hidalgo, 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology, 96, 736, 10.1016/S0016-5085(89)80072-1 Hidalgo, 1990, Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2, Biochim. Biophys. Acta, 1028, 25, 10.1016/0005-2736(90)90261-L Hidalgo, 1990, Transport of bile acids in a human intestinal epithelial cell line, Caco-2, Biochim. Biophys. Acta, 1035, 97, 10.1016/0304-4165(90)90179-Z Hilgers, 1990, Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa, Pharm. Res., 7, 902, 10.1023/A:1015937605100 Hogben, 1959, On the mechanism of intestinal absorption of drugs, J. Pharmacol. Exp. Ther., 125, 275 Kimura, 1972, Effect of bile salts on the gastrointestinal absorption of drugs. IV. Site of intestinal absorption of sodium taurocholate and its consequence on drug absorption in the rat, Chem. Pharm. Bull., 20, 1656, 10.1248/cpb.20.1656 Lennernas, 1996, Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo, Int. J. Pharm., 127, 103, 10.1016/0378-5173(95)04204-0 Lucas, 1975, Direct measurement by pH-microelectrode of the pH microclimate in rat proximal jejunum, Proc. R. Soc. London B, 192, 39, 10.1098/rspb.1975.0150 Lucas, 1983, Determination of acid surface pH in vivo in rat proximal jejunum, Gut, 24, 734, 10.1136/gut.24.8.734 Matsumoto, 1994, Transcellular transport of oral cephalos-porins in human intestinal epithelial cells, Caco-2: Interaction with dipeptide transport systems in apical and basolateral membranes, J. Pharmacol. Exp. Ther., 270, 498 Peeters, 1980, Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients, Gastroenterology, 79, 678, 10.1016/0016-5085(80)90244-9 Rao, 1997, A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions, J. Pharm. Sci., 86, 1132, 10.1021/js9604974 Rubas, 1993, Comparison of the permeability characteristics of human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption, Pharm. Res., 10, 113, 10.1023/A:1018937416447 Shiah, 1985, Mechanisms maintaining a low-pH microclimate in the intestine, Am. J. Physiol., 248, G608 Sietsema, 1989, The absolute oral bioavailability of selected drugs, Int. J. Clin. Phamacol., 27, 179 Stewart, 1995, Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: Relations to absorption in humans, Pharm. Res., 12, 693, 10.1023/A:1016207525186 Sugiyama, 1997, Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro using chamber method: Correlation with an in situ absorption experiment, Biol. Pharm. Bull., 20, 812, 10.1248/bpb.20.812 Takagi, 1998, A new interpretation of salicylic acid transport across the lipid bilayer: Implication of pH-dependent but not carrier-mediated absorption from the gastrointestinal tract, J. Pharmacol. Exp. Ther., 285, 1175 Takanaga, 1994, pH-dependent and carrier-mediated transport of salicylic acid across Caco-2 cells, J. Pharm. Pharmacol., 46, 567, 10.1111/j.2042-7158.1994.tb03858.x Takanaga, 1995, cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter, Biochim. Biophys. Res. Commun., 217, 370, 10.1006/bbrc.1995.2786 Tamai, 1995, Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids, Biochim. Biophys. Res. Commun., 214, 482, 10.1006/bbrc.1995.2312 Tanaka, 1995, Characterization of drug transport through tight-junctional pathway in Caco-2 monolayer: Comparison with isolated rat jejunum and colon, Pham. Res., 12, 523, 10.1023/A:1016245711557 Tangerman, 1986, Analysis of conjugated and unconjugated bile acids in serum and jejunal fluid of normal subjects, Clin. Chim. Acta, 159, 123, 10.1016/0009-8981(86)90044-6 Yamashita, 1990, Effect of adjuvant on charge-selective permeability and electrical resistance of rat jejunal membrane, J. Pharm. Sci., 79, 579, 10.1002/jps.2600790706 Yamashita, 1997, Analysis of drug permeation across Caco-2 monolayer: Implication for predicting in vivo drug absorption, Pharm. Res., 14, 486, 10.1023/A:1012103700981 Yamamoto, 1996, Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: Effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane, J. Pharm. Pharmacol., 48, 1285, 10.1111/j.2042-7158.1996.tb03937.x Yamaoka, 1981, A pharmacokinetic analysis program (MULTI) for microcomputer, J. Pharmacobio-Dyn., 4, 879, 10.1248/bpb1978.4.879 Yazdanian, 1998, Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds, Pham. Res., 15, 1490, 10.1023/A:1011930411574 Yee, 1997, In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man — Fact or myth, Pharm. Res., 14, 763, 10.1023/A:1012102522787